Durham, NC 的 黑色素瘤 臨床試驗
21 項針對 黑色素瘤 的研究正在 Durham（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
招募中觀察性研究歡迎健康志工
- Durham VA Medical Center, Durham
NeoAdjuvant, Spare-Adjuvant (NASA) in Stage IIIB-IV (M1a) Melanoma
招募中2 期
- Lineberger Comprehensive Cancer Center, Chapel Hill · 距離 10 英里
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
招募中3 期
- Duke Health System, Durham
Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma
招募中3 期
- Duke University Medical Center, Durham
A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
招募中2 期
- Local Institution - 0100, Durham
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
招募中觀察性研究
- UNC- Chapel Hill, Chapel Hill · 距離 10 英里
DOC1021 Dendritic Cell Immunotherapy for Refractory Melanoma
招募中1/2 期
- University of North Carolina, Chapel Hill · 距離 10 英里
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
招募中1/2 期
- Duke Cancer Institute, Durham
Project: Every Child for Younger Patients With Cancer
招募中觀察性研究
- Duke University Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 距離 10 英里
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
招募中1 期
- Lineberger Comprehensive Cancer Center, Chapel Hill · 距離 10 英里
A Feasibility Study Utilizing Immune Recall to Increase Response to Checkpoint Therapy
招募中1 期
- Duke University Medical Center, Durham
A Study to Investigate the Safety and Efficacy of IOV-3001 in Adults With Advanced Melanoma Who Will Receive Lifileucel
招募中1/2 期
- UNC Hospitals, The University of North Carolina at Chapel Hill, Chapel Hill · 距離 10 英里
Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions
招募中1/2 期
- Duke University Medical Center, Durham
IL-17 Blockade to Decrease irAEs (REPLAY)
招募中1 期
- Duke University Health System, Durham
A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body
招募中1/2 期
- University of North Carolina at Chapel Hill, Chapel Hill · 距離 10 英里
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
招募中2/3 期
- Duke University Medical Center, Durham
Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients
招募中3 期
- Duke University Medical Center - Duke Cancer Center, Durham
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中觀察性研究
- Massive Bio SYNERGY-AI site, Chapel Hill · 距離 10 英里
Excision of Lymph Node Trial (EXCILYNT) (Mel69)
招募中
- Duke University Health System, Durham
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
招募中
- Duke University Medical Center, Durham
- University of North Carolina at Chapel Hill, Chapel Hill · 距離 10 英里
- University of North Carolina Hospitals - Hillsborough Campus, Hillsborough · 距離 13 英里
其他城市的 黑色素瘤 試驗
- Houston, TX59 項研究
- New York City, NY38 項研究
- Los Angeles, CA34 項研究
- Nashville, TN33 項研究
- Pittsburgh, PA31 項研究
- Boston, MA26 項研究
- Philadelphia, PA23 項研究
- San Francisco, CA22 項研究
- St. Louis, MO21 項研究
- Atlanta, GA21 項研究
- Columbus, OH21 項研究
- Salt Lake City, UT21 項研究
Durham 的其他研究
- 乳癌64 項研究
- 癌症（所有類型）58 項研究
- 非小細胞肺癌39 項研究
- 多發性骨髓瘤37 項研究
- 急性髓系白血病33 項研究
- 轉移性癌症33 項研究
- 前列腺癌32 項研究
- 肺癌32 項研究
- 大腸直腸癌28 項研究
- 卵巢癌27 項研究
- 慢性淋巴性白血病27 項研究
- 心臟衰竭26 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。